GlycoMimetics, Inc. (NASDAQ: GLYC) today announced that Rachel King,
Chief Executive Officer, will be presenting at the 16th Annual BIO CEO &
Investor Conference on Tuesday, February 11, 2014 at 1:30 p.m. Eastern
Time. Hosted by the Biotechnology Industry Organization (BIO), the
Conference will take place February 10-11 at the Waldorf Astoria in New
York City.
To access the live webcast and subsequent archived recordings for the
presentation, please visit the GlycoMimetics website at www.glycomimetics.com.
About GlycoMimetics, Inc.
GlycoMimetics is a clinical stage biotechnology company focused on the
discovery and development of novel glycomimetic drugs to address unmet
medical needs resulting from diseases in which carbohydrate biology
plays a key role. Glycomimetics are molecules that mimic the structure
of carbohydrates involved in important biological processes. Using its
expertise in carbohydrate chemistry and knowledge of carbohydrate
biology, GlycoMimetics is developing a pipeline of glycomimetic drug
candidates that inhibit disease-related functions of carbohydrates, such
as the roles they play in inflammation, cancer and infection.
Copyright Business Wire 2014